EP3119384
Meðhöndlun gallteppusjúkdóma innan lifrar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
19.3.2015EP published:
12.9.2018EP application number:
15714132.6
EP translation filed:
31.10.2018Grant published:
15.11.2018EPO information:
European Patent Register
Max expiry date:
18.3.2035Expiry date:
18.3.2027Next due date:
31.3.2027
Timeline
Today
19.3.2015EP application
12.9.2018EP Publication
31.10.2018Translation submitted
15.11.2018Registration published
18.3.2027Expires
Owner
Name:
CymaBay Therapeutics, Inc.Address:
333 Lakeside Drive, 94404, Foster City, CA, US
Inventor
Name:
Pol BoudesAddress:
Newark, US
Name:
Charles A. McwherterAddress:
Newark, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461968037 PDate:
20.3.2014Country:
US
Supplementary protection
SPC number:
SPC519
Classification
Categories:
A61K 31/09, A61P 1/16, A61K 31/192
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 7.2.2019
Expires: 18.3.2020
Payer: Árnason Faktor
Number: 6
Paid: 24.2.2020
Expires: 18.3.2021
Payer: Árnason Faktor ehf.
Number: 7
Paid: 8.2.2021
Expires: 18.3.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 8.2.2022
Expires: 18.3.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 8.2.2023
Expires: 18.3.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 14.2.2024
Expires: 18.3.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 11.2.2025
Expires: 18.3.2026
Payer: Árnason Faktor ehf.
Number: 12
Paid: 9.3.2026
Expires: 18.3.2027
Payer: Árnason Faktor ehf.